FI924019L - Menetelmä vesipitoisen suspensiovalmisteen tuottamiseksi - Google Patents

Menetelmä vesipitoisen suspensiovalmisteen tuottamiseksi Download PDF

Info

Publication number: FI924019L
Authority: FI; Finland
Prior art keywords: producing; aqueous suspension; suspension preparation; preparation; aqueous
Prior art date: 1990-03-20

Application number

FI924019A

Other languages

English (en)

Swedish (sv)

Other versions

FI924019A0 (fi

FI98890B (fi

FI98890C (fi

Inventor

Eric Willem Ackerman

Rene Jacobus Elisabert Grouls

Hendrikus Hubertus Mar Korsten

Original Assignee

Ziekenhuis Stichting Catharina

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-03-20

Filing date

1992-09-08

Publication date

1992-09-08

1992-09-08 Application filed by Ziekenhuis Stichting Catharina filed Critical Ziekenhuis Stichting Catharina

1992-09-08 Publication of FI924019L publication Critical patent/FI924019L/fi

1992-09-08 Publication of FI924019A0 publication Critical patent/FI924019A0/fi

1997-05-30 Publication of FI98890B publication Critical patent/FI98890B/fi

1997-09-10 Application granted granted Critical

1997-09-10 Publication of FI98890C publication Critical patent/FI98890C/fi

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oil, Petroleum & Natural Gas (AREA)
Anesthesiology (AREA)
Dermatology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biochemistry (AREA)
Emergency Medicine (AREA)
Molecular Biology (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)

FI924019A 1990-03-20 1992-09-08 Menetelmä vesipitoisen suspensiovalmisteen tuottamiseksi FI98890C (fi)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
NL9000634		1990-03-20
NL9000634A NL9000634A (nl)	1990-03-20	1990-03-20	Suspensie-injectiepreparaat op waterbasis, werkwijze voor de bereiding daarvan en toepassing van dit preparaat voor pijnbestrijding.
NL9100042		1991-03-20
PCT/NL1991/000042 WO1991014455A1 (en)	1990-03-20	1991-03-20	Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief

Publications (4)

Publication Number	Publication Date
FI924019L true FI924019L (fi)	1992-09-08
FI924019A0 FI924019A0 (fi)	1992-09-08
FI98890B FI98890B (fi)	1997-05-30
FI98890C FI98890C (fi)	1997-09-10

Family

ID=19856770

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
FI924019A FI98890C (fi)	1990-03-20	1992-09-08	Menetelmä vesipitoisen suspensiovalmisteen tuottamiseksi

Country Status (15)

Country	Link
US (1)	US5346903A (fi)
EP (1)	EP0521070B1 (fi)
JP (1)	JPH05507466A (fi)
AT (1)	ATE121631T1 (fi)
AU (1)	AU646857B2 (fi)
BR (1)	BR1100601A (fi)
CA (1)	CA2077641C (fi)
DE (1)	DE69109279T2 (fi)
DK (1)	DK0521070T3 (fi)
ES (1)	ES2074269T3 (fi)
FI (1)	FI98890C (fi)
GR (1)	GR3015940T3 (fi)
NL (1)	NL9000634A (fi)
NO (1)	NO300114B1 (fi)
WO (1)	WO1991014455A1 (fi)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5206267A (en) *	1991-05-09	1993-04-27	Morton Shulman	Pain controlling composition and method of preparation
US5635540A (en) *	1994-12-09	1997-06-03	The University Of Virginia Patent Foundation	Stabilized topical pharmaceutical preparations
US6077545A (en)	1995-10-30	2000-06-20	Matrix Pharmaceuticals, Inc.	Process and composition for therapeutic cisplatin (CDDP)
RO121117B1 (ro) *	1996-03-26	2006-12-29	Eli Lilly And Company	Compoziţie farmaceutică conţinând derivaţi de benzotiofen şi utilizarea acesteia
US6541021B1 (en) *	1999-03-18	2003-04-01	Durect Corporation	Devices and methods for pain management
US6835194B2 (en)	1999-03-18	2004-12-28	Durect Corporation	Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
US7074803B2 (en) *	2001-03-02	2006-07-11	Durect Corporation	Opioid formulations
CA2740056A1 (en)	2001-04-24	2002-11-21	Purdue Research Foundation	Methods and compositions for treating mammalian nerve tissue injuries
US20030181426A1 (en) *	2002-02-11	2003-09-25	Eisenach James C.	Compositions and methods for treating pain using cyclooxygenase-1 inhibitors
US7838034B2 (en)	2002-07-30	2010-11-23	Grunenthal Gmbh	Intravenous pharmaceutical form of administration
DE10234784A1 (de) *	2002-07-30	2004-02-19	Günenthal GmbH	Intravenös applizierbare, pharmazeutische Darreichungsform
US20040102476A1 (en) *	2002-11-25	2004-05-27	Chan Tai Wah	High concentration formulations of opioids and opioid derivatives
CA2512052C (en) *	2002-12-31	2016-06-21	Altus Pharmaceuticals Inc.	Human growth hormone crystals and methods for preparing them
ZA200505306B (en) *	2002-12-31	2006-09-27	Altus Pharmaceuticals Inc	Complexes of protein crystals and ionic polymers
GB0300531D0 (en)	2003-01-10	2003-02-12	West Pharm Serv Drug Res Ltd	Pharmaceutical compositions
US20090023629A1 (en) *	2005-12-23	2009-01-22	Altus Pharmaceuticals Inc.	Compositions comprising polycation-complexed protein crystals and methods of treatment using them
US8071544B2 (en) *	2006-12-18	2011-12-06	Althea Technologies, Inc.	Crystallized recombinant human growth factor formulations
FI20075091A0 (fi) *	2007-02-09	2007-02-09	Kim Lemberg	Noroksimorfoni käytettäväksi lääkeaineena
US20080227805A1 (en) *	2007-02-28	2008-09-18	Abbott Laboratories	Sustained release parenteral formulations of buprenorphine
US9125867B2 (en) *	2010-02-24	2015-09-08	Invincible Biotechnology	Diversion- and/or abuse-resistant compositions and methods for making the same
GB2481017B (en) *	2010-06-08	2015-01-07	Rb Pharmaceuticals Ltd	Microparticle buprenorphine suspension
US9272044B2 (en)	2010-06-08	2016-03-01	Indivior Uk Limited	Injectable flowable composition buprenorphine
GB201404139D0 (en)	2014-03-10	2014-04-23	Rb Pharmaceuticals Ltd	Sustained release buprenorphine solution formulations
CA3015557C (en)	2014-11-07	2019-07-16	Indivior Uk Limited	The use of sustained-release buprenorphine formulations for the treatment of pain or opioid use disorders
US10646484B2 (en)	2017-06-16	2020-05-12	Indivior Uk Limited	Methods to treat opioid use disorder
CN114222565B (zh) *	2019-10-16	2023-10-20	广东东阳光药业股份有限公司	一种药物组合物
WO2022175977A1 (en) *	2021-02-18	2022-08-25	Navin Saxena Research And Technology Private Limited	A biodegradable implant composition and process for long term delivery of buprenorphine and use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB784659A (en) *	1954-11-26	1957-10-16	Upjohn Co	Therapeutic compositions and aqueous suspensions thereof
US3337406A (en) *	1963-12-12	1967-08-22	Mar Sal Inc	Treatment of arteriosclerotic diseases
EP0031603A1 (en) *	1979-12-31	1981-07-08	American Cyanamid Company	Pharmaceutical composition of matter
US4963367A (en) *	1984-04-27	1990-10-16	Medaphore, Inc.	Drug delivery compositions and methods
US4599354A (en) *	1985-03-11	1986-07-08	Morton Shulman	Composition and method for producing prolonged pain relief

1990
- 1990-03-20 NL NL9000634A patent/NL9000634A/nl not_active Application Discontinuation
1991
- 1991-03-20 WO PCT/NL1991/000042 patent/WO1991014455A1/en not_active Ceased
- 1991-03-20 AT AT91906827T patent/ATE121631T1/de not_active IP Right Cessation
- 1991-03-20 ES ES91906827T patent/ES2074269T3/es not_active Expired - Lifetime
- 1991-03-20 CA CA002077641A patent/CA2077641C/en not_active Expired - Fee Related
- 1991-03-20 EP EP91906827A patent/EP0521070B1/en not_active Expired - Lifetime
- 1991-03-20 DK DK91906827.0T patent/DK0521070T3/da active
- 1991-03-20 DE DE69109279T patent/DE69109279T2/de not_active Expired - Fee Related
- 1991-03-20 AU AU75580/91A patent/AU646857B2/en not_active Ceased
- 1991-03-20 JP JP91507032A patent/JPH05507466A/ja active Pending
1992
- 1992-09-03 NO NO923429A patent/NO300114B1/no unknown
- 1992-09-08 FI FI924019A patent/FI98890C/fi not_active IP Right Cessation
- 1992-11-20 US US07/979,128 patent/US5346903A/en not_active Expired - Lifetime
1995
- 1995-04-27 GR GR950400877T patent/GR3015940T3/el unknown
1997
- 1997-05-13 BR BR1100601-3A patent/BR1100601A/pt active IP Right Grant

Also Published As

Publication number	Publication date
DK0521070T3 (da)	1995-05-22
CA2077641C (en)	2001-07-03
US5346903A (en)	1994-09-13
NO923429L (no)	1992-09-17
NO923429D0 (no)	1992-09-03
WO1991014455A1 (en)	1991-10-03
FI924019A0 (fi)	1992-09-08
CA2077641A1 (en)	1991-09-21
AU7558091A (en)	1991-10-21
EP0521070A1 (en)	1993-01-07
BR1100601A (pt)	2000-04-18
FI98890B (fi)	1997-05-30
ATE121631T1 (de)	1995-05-15
ES2074269T3 (es)	1995-09-01
NL9000634A (nl)	1991-10-16
DE69109279T2 (de)	1995-11-09
JPH05507466A (ja)	1993-10-28
NO300114B1 (no)	1997-04-14
FI98890C (fi)	1997-09-10
GR3015940T3 (en)	1995-07-31
EP0521070B1 (en)	1995-04-26
DE69109279D1 (de)	1995-06-01
AU646857B2 (en)	1994-03-10

Publication	Publication Date	Title
FI924019L (fi)	1992-09-08	Menetelmä vesipitoisen suspensiovalmisteen tuottamiseksi
FI890339A7 (fi)	1989-07-28	Menetelmä tupakkauutteiden tuottamiseksi
FI905210A7 (fi)	1991-04-26	Menetelmä natriumsilikaattien valmistamiseksi
FI945856A0 (fi)	1994-12-13	Menetelmä level-off-DP-selluloosan valmistamiseksi
FI893158L (fi)	1989-12-30	Menetelmä tetrahydrofolaattien valmistamiseksi
FI905209A7 (fi)	1991-04-26	Menetelmä natriumsilikaattien valmistamiseksi
HU913836D0 (en)	1992-02-28	Method for producing alpha-oxoacetamide derivatives
FI915741A7 (fi)	1991-12-05	Parannettu menetelmä substituoitujen isoflavonijohdannaisten valmistam iseksi
FI914538A7 (fi)	1991-09-26	Parannettu menetelmä massan valmistamiseksi
FI911601L (fi)	1991-10-05	Menetelmä pigmentin valmistamiseksi
FI891711L (fi)	1989-12-26	Menetelmä diorganodialkoksisilaanien valmistamiseksi
FI905536A7 (fi)	1991-05-14	Menetelmä N-glykosidijohdannaisten valmistamiseksi
FI895676L (fi)	1991-05-28	Menetelmä massan valmistamiseksi
FI95036B (fi)	1995-08-31	Tieno-triatsolo-diatsepiinijohdosten valmistusmenetelmä
FI883661L (fi)	1989-02-09	Menetelmä eetteröityjen tärkkelysten valmistamiseksi
FI923498A7 (fi)	1993-02-07	Menetelmä 3-deoksimannosamiini-johdannaisten valmistamiseksi
FI952890A7 (fi)	1995-12-21	Menetelmä vesipitoisen kopolymeriliuoksen valmistamiseksi
FI906203A7 (fi)	1991-06-23	Glyserolijohdosten valmistusmenetelmä
FI924371A7 (fi)	1992-09-29	Menetelmä sähkömagneettisen muuttimen valmistamiseksi
FI940471L (fi)	1994-03-10	Menetelmä vesipitoisen kalsiumsulfaattipohjaisen suspension valmistamiseksi
FI900663L (fi)	1991-08-10	Menetelmä sulfaattimassan valmistamiseksi
FI911812A7 (fi)	1991-11-09	Menetelmä ksylanaasin valmistamiseksi
FI901770L (fi)	1991-10-07	Menetelmä alkalimetallifosfaatin valmistamiseksi
FI912163L (fi)	1991-11-05	Menetelmä substituoitujen indolien valmistamiseksi
FI900544A7 (fi)	1991-10-18	Menetelmä massan valmistamiseksi

Legal Events

Date	Code	Title	Description
1997-05-05	BB	Publication of examined application
2007-09-30	MA	Patent expired